Insider Transactions in Q4 2021 at Ironwood Pharmaceuticals Inc (IRWD)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2021
|
Thomas A Mccourt Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
46,327
-7.46%
|
$509,597
$11.41 P/Share
|
|
Dec 16
2021
|
Jason Rickard SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
27,000
-7.78%
|
$297,000
$11.28 P/Share
|
|
Dec 15
2021
|
Catherine Moukheibir |
BUY
Grant, award, or other acquisition
|
Direct |
1,541
+1.98%
|
-
|
|
Dec 15
2021
|
Andrew Dreyfus |
BUY
Grant, award, or other acquisition
|
Direct |
1,431
+1.09%
|
-
|
|
Dec 15
2021
|
Alexander J Denner |
BUY
Grant, award, or other acquisition
|
Direct |
1,211
+1.82%
|
-
|
|
Dec 14
2021
|
Julie Mc Hugh |
SELL
Open market or private sale
|
Direct |
10,000
-6.74%
|
$110,000
$11.02 P/Share
|
|
Dec 06
2021
|
Sravan Kumar Emany SVP, COO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+50.0%
|
-
|
|
Nov 23
2021
|
Ronald Silver Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,462
-1.17%
|
$16,082
$11.58 P/Share
|
|
Nov 23
2021
|
Michael Shetzline CMO,SVP,Head-Res&Drug |
SELL
Open market or private sale
|
Direct |
13,776
-6.98%
|
$151,536
$11.58 P/Share
|
|
Nov 23
2021
|
Jason Rickard SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
17,193
-2.38%
|
$189,123
$11.58 P/Share
|
|
Nov 23
2021
|
Thomas A Mccourt Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
52,644
-7.84%
|
$579,084
$11.58 P/Share
|